BRAIN Biotech AG

XTRA:BNN Stok Raporu

Piyasa değeri: €68.8m

BRAIN Biotech Yönetim

Yönetim kriter kontrolleri 2/4

Şu anda CEO hakkında yeterli bilgiye sahip değiliz.

Anahtar bilgiler

Aryan Moelker

İcra Kurulu Başkanı

n/a

Toplam tazminat

CEO maaş yüzdesin/a
CEO görev süresi4.8yrs
CEO sahipliğin/a
Yönetim ortalama görev süresi3.1yrs
Yönetim Kurulu ortalama görev süresi4.1yrs

Son yönetim güncellemeleri

Recent updates

Further Upside For BRAIN Biotech AG (ETR:BNN) Shares Could Introduce Price Risks After 27% Bounce

Nov 12
Further Upside For BRAIN Biotech AG (ETR:BNN) Shares Could Introduce Price Risks After 27% Bounce

Further Upside For BRAIN Biotech AG (ETR:BNN) Shares Could Introduce Price Risks After 50% Bounce

Sep 24
Further Upside For BRAIN Biotech AG (ETR:BNN) Shares Could Introduce Price Risks After 50% Bounce

BRAIN Biotech AG (ETR:BNN) Screens Well But There Might Be A Catch

Aug 06
BRAIN Biotech AG (ETR:BNN) Screens Well But There Might Be A Catch

Is BRAIN Biotech (ETR:BNN) Weighed On By Its Debt Load?

Jun 29
Is BRAIN Biotech (ETR:BNN) Weighed On By Its Debt Load?

BRAIN Biotech AG (ETR:BNN) Shares Could Be 36% Below Their Intrinsic Value Estimate

Apr 19
BRAIN Biotech AG (ETR:BNN) Shares Could Be 36% Below Their Intrinsic Value Estimate

BRAIN Biotech AG's (ETR:BNN) P/S Still Appears To Be Reasonable

Mar 28
BRAIN Biotech AG's (ETR:BNN) P/S Still Appears To Be Reasonable

Is BRAIN Biotech (ETR:BNN) A Risky Investment?

Feb 16
Is BRAIN Biotech (ETR:BNN) A Risky Investment?

Here's Why BRAIN Biotech (ETR:BNN) Can Afford Some Debt

Sep 13
Here's Why BRAIN Biotech (ETR:BNN) Can Afford Some Debt

Here's What B.R.A.I.N. Biotechnology Research and Information Network AG's (ETR:BNN) Shareholder Ownership Structure Looks Like

Mar 21
Here's What B.R.A.I.N. Biotechnology Research and Information Network AG's (ETR:BNN) Shareholder Ownership Structure Looks Like

Is B.R.A.I.N. Biotechnology Research and Information Network (ETR:BNN) Weighed On By Its Debt Load?

Feb 14
Is B.R.A.I.N. Biotechnology Research and Information Network (ETR:BNN) Weighed On By Its Debt Load?

When Will B.R.A.I.N. Biotechnology Research and Information Network AG (ETR:BNN) Breakeven?

Jan 18
When Will B.R.A.I.N. Biotechnology Research and Information Network AG (ETR:BNN) Breakeven?

How Much Did B.R.A.I.N. Biotechnology Research and Information Network's(ETR:BNN) Shareholders Earn From Share Price Movements Over The Last Three Years?

Dec 31
How Much Did B.R.A.I.N. Biotechnology Research and Information Network's(ETR:BNN) Shareholders Earn From Share Price Movements Over The Last Three Years?

Are Institutions Heavily Invested In B.R.A.I.N. Biotechnology Research and Information Network AG's (ETR:BNN) Shares?

Dec 10
Are Institutions Heavily Invested In B.R.A.I.N. Biotechnology Research and Information Network AG's (ETR:BNN) Shares?

Should You Investigate B.R.A.I.N. Biotechnology Research and Information Network AG (ETR:BNN) At €7.30?

Nov 17
Should You Investigate B.R.A.I.N. Biotechnology Research and Information Network AG (ETR:BNN) At €7.30?

CEO Tazminat Analizi

Aryan Moelker'un ücretlendirmesi BRAIN Biotech'un kazancına kıyasla nasıl değişti?
TarihToplam TazminatMaaşŞirket Kazançları
Jun 30 2024n/an/a

-€9m

Mar 31 2024n/an/a

-€8m

Dec 31 2023n/an/a

-€8m

Sep 30 2023n/an/a

-€8m

Jun 30 2023n/an/a

-€7m

Mar 31 2023n/an/a

-€7m

Dec 31 2022n/an/a

-€7m

Sep 30 2022n/an/a

-€7m

Jun 30 2022n/an/a

-€8m

Mar 31 2022n/an/a

-€8m

Dec 31 2021n/an/a

-€4m

Sep 30 2021€957k€420k

-€5m

Jun 30 2021n/an/a

-€6m

Mar 31 2021n/an/a

-€6m

Dec 31 2020n/an/a

-€11m

Sep 30 2020€885k€280k

-€10m

Tazminat ve Piyasa: Aryan şirketinin toplam tazminatının German pazarındaki benzer büyüklükteki şirketlerle karşılaştırıldığında makul olup olmadığını tespit etmek için yeterli veri yok.

Tazminat ve Kazançlar: Aryan şirketinin tazminatı, şirket kârsız olduğu sürece artırıldı.

CEO

Aryan Moelker

4.8yrs

Görev süresi

€957,000

Tazminat

Mr. Adriaan Moelker, also known as Aryan, serves as Director of SolasCure Limited. He has been Chairman of the Management Board and Chief Executive Officer of BRAIN Biotech AG (formerly known as B.R.A.I.N....

Liderlik Ekibi

İsimPozisyonGörev süresiTazminatSahiplik
Adriaan Moelker
Chairman of the Management Board & CEO4.8yrs€957.00kVeri yok
Ulrich Putsch
Co-Founderno dataVeri yokVeri yok
Michael Schneiders
CFO & Member of Management Board2.1yrsVeri yokVeri yok
Ute Dechert
Vice President of Human Resources & Processes4.1yrsVeri yokVeri yok
Jurgen Eck
Consultant4.9yrs€392.00kVeri yok
Martin Langer
MD & Executive VPno dataVeri yokVeri yok
Alexander Pelzer
VP and Head of Research & Development - Zwingenberg1.8yrsVeri yokVeri yok
Robbert Hoekstra
Head of Group Finance2.1yrsVeri yokVeri yok
Paul Scholz
Technical Lead of Genome Editing Developmentno dataVeri yokVeri yok

3.1yrs

Ortalama Görev Süresi

56.5yo

Ortalama Yaş

Deneyimli Yönetim: BNN 'un yönetim ekibi deneyimli olarak değerlendirilmektedir (ortalama görev süresi 3.1 yıldır).

Yönetim Kurulu Üyeleri

İsimPozisyonGörev süresiTazminatSahiplik
Stephen Catling
Independent Member of Supervisory Board4.1yrs€31.00kVeri yok
Michael Majerus
Independent Chairman of the Supervisory Board5.7yrs€51.00kVeri yok
Anna Eichhorn
Vice Chairwoman of the Supervisory Board7.7yrs€53.00kVeri yok
Christine Uekert
Independent Supervisory Board Member1.7yrsVeri yokVeri yok
Florian Schnabel
Supervisory Board Member1.7yrsVeri yokVeri yok

4.1yrs

Ortalama Görev Süresi

57yo

Ortalama Yaş

Deneyimli Yönetim Kurulu: BNN 'nin yönetim kurulu üyeleri deneyimli olarak kabul edilir (ortalama görev süresi 4.1 yıldır).